MoneyWorks4Me

Neuland Laboratories informs about earnings call

28 Oct 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015, Neuland Laboratories has informed that it enclosed the schedule of Q2 FY 2026 Earnings Call details.

The above information is a part of company’s filings submitted to BSE.  

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..